New therapeutic target for non-small-cell lung cancer

被引：5
|
作者：
Sharma, Sharan Prakash
机构：
来源：
LANCET ONCOLOGY | 2014年 / 15卷 / 12期
关键词：
D O I：
10.1016/S1470-2045(14)70493-0
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：E533 / E533
页数：1
相关论文
共 50 条
  • [1] Epiregulin as a therapeutic target in non-small-cell lung cancer
    Sunaga, Noriaki
    Kaira, Kyoichi
    LUNG CANCER-TARGETS AND THERAPY, 2015, 6 : 91 - 98
  • [2] Src as a potential therapeutic target in non-small-cell lung cancer
    Giaccone, G.
    Zucali, P. A.
    ANNALS OF ONCOLOGY, 2008, 19 (07) : 1219 - 1223
  • [3] Surviving as a therapeutic target and biomarker for non-small-cell lung cancer.
    Lu, B
    Gonzalez, A
    Massion, P
    Shyre, Y
    Carbone, D
    Hallahan, D
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 654S - 654S
  • [4] MET As a Possible Target for Non-Small-Cell Lung Cancer
    Sadiq, Ahad A.
    Salgia, Ravi
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (08) : 1089 - 1096
  • [5] Validating ROS1 Rearrangements As a Therapeutic Target in Non-Small-Cell Lung Cancer
    Solomon, Benjamin
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (09) : 972 - 974
  • [6] Thrombin is a therapeutic target for non-small-cell lung cancer to inhibit vasculogenic mimicry formation
    Zhao, Bing
    Wu, Mengfang
    Hu, Zhihuang
    Ma, Yixin
    Qi, Wang
    Zhang, Yanling
    Li, Yaran
    Yu, Min
    Wang, Huijie
    Mo, Wei
    SIGNAL TRANSDUCTION AND TARGETED THERAPY, 2020, 5 (01)
  • [7] Thrombin is a therapeutic target for non-small-cell lung cancer to inhibit vasculogenic mimicry formation
    Bing Zhao
    Mengfang Wu
    Zhihuang Hu
    Yixin Ma
    Wang Qi
    Yanling Zhang
    Yaran Li
    Min Yu
    Huijie Wang
    Wei Mo
    Signal Transduction and Targeted Therapy, 5
  • [8] In vitro study of FUZ as a novel potential therapeutic target in non-small-cell lung cancer
    He, Minwei
    Li, Kangqi
    Yu, Chuanfei
    Lv, Bingfeng
    Zhao, Ning
    Deng, Jinhai
    Cao, Lulu
    Huang, He
    Yin, Ang
    Shi, Taiping
    Wang, Lu
    LIFE SCIENCES, 2018, 197 : 91 - 100
  • [9] RUMI is a novel negative prognostic marker and therapeutic target in non-small-cell lung cancer
    Chammaa, May
    Malysa, Agnes
    Redondo, Carlos
    Jang, Hyejeong
    Chen, Wei
    Bepler, Gerold
    Fernandez-Valdivia, Rodrigo
    JOURNAL OF CELLULAR PHYSIOLOGY, 2018, 233 (12) : 9548 - 9562
  • [10] Therapeutic cancer vaccines in the treatment of non-small-cell lung cancer
    Limacher, Jean-Marc
    Spring-Giusti, Clementine
    Bellon, Nadine
    Ancian, Philippe
    Rooke, Ronald
    Bonnefoy, Jean-Yves
    EXPERT REVIEW OF VACCINES, 2013, 12 (03) : 263 - 270
12345